首页> 外国专利> A VACCINE FOR COMBATTING PLEUROPNEUMONIA IN PIGS,AND A PROCESS AND A SUBSTRATE FOR THE AEROBIC FERMENTATION OF HAEMOPHILUS PLEUROPNEUMONIAE

A VACCINE FOR COMBATTING PLEUROPNEUMONIA IN PIGS,AND A PROCESS AND A SUBSTRATE FOR THE AEROBIC FERMENTATION OF HAEMOPHILUS PLEUROPNEUMONIAE

机译:猪肺炎肺炎疫苗及嗜血肺炎肺炎菌需氧发酵的方法和物质

摘要

In an improved method for combatting pleuropneumonia in pigs by administering a vaccine comprising cells of the known and generally available microorganism Haemophilus pleuropneumoniae, parts of such cells, extracts and/or metabolism products thereof as the active ingredient, adjuvants and a buffer, the improvement consisting in the use of a Bordetella pertussis vaccine, biomass and/or extracts thereof as adjuvant, as well as the new H. pleuropneumoniae vaccine comprising a B. pertussis based adjuvant. The method and the vaccine result in an improved protection of the pigs against pleuropneumonia attacks without side-effects. Besides, a new and improved substrate called CAY-substrate for the cultivation of microorganisms, in particular the bacterium H. pleuropneumoniae, which compared to known substrates results in a substantially higher yield of biomass suitable for the production of a H. pleuropneumoniae vaccine, said substrate comprising casamino acid, yeast extract, glucose and NAD as essential ingredients and being suitable for cultivation of H. pleuropneumoniae on solid as well as in liquid media by slight modifications in the composition of the substrate. An improved process for the aerobic fermentation of H. pleuropneumoniae in a liquid medium comprising the new CAY-substrate, the fermentation being advantageously performed at a temperature of about 37 C., a pH of about 7.1 to 7.4, and at an oxygen concentration in the fermentation medium of about 8 to 12 ppm, thereby maintaining the desired oxygen concentration by variation of the stirring speed and/or of the air flow rate.
机译:在一种改进的抗猪胸膜肺炎的方法中,通过施用一种疫苗,该疫苗包含已知的和普遍可得的微生物胸膜肺炎嗜血杆菌的细胞,这些细胞的一部分,其提取物和/或其代谢产物作为活性成分,佐剂和缓冲剂,该改进包括在使用百日咳博德特氏菌疫苗,生物量和/或其提取物作为佐剂以及包含基于百日咳博德特氏菌的佐剂的新型胸膜肺炎支原体疫苗中的应用。该方法和疫苗导致对猪的抗胸膜肺炎发作的保护得到改善,而没有副作用。此外,一种新的改良的被称为CAY-底物的用于培养微生物,特别是细菌肺炎嗜血杆菌的底物,与已知的底物相比,导致适于生产胸膜肺炎疫苗的生物质的产量大大提高。包含酪蛋白氨基酸,酵母提取物,葡萄糖和NAD作为基本成分的底物,通过稍微改变底物的组成,适合在固体以及液体培养基中培养胸膜肺炎支原体。一种在包含新的CAY底物的液体培养基中对胸膜肺炎链球菌进行好氧发酵的改进方法,该发酵有利地在约37°C的温度,约7.1至7.4的pH值和氧气浓度下进行。发酵培养基的浓度约为8至12 ppm,从而通过改变搅拌速度和/或空气流速来保持所需的氧气浓度。

著录项

  • 公开/公告号WO8002113A1

    专利类型

  • 公开/公告日1980-10-16

    原文格式PDF

  • 申请/专利号WO1980DK00021

  • 发明设计人

    申请日1980-04-02

  • 分类号A61K39/116;A61K39/102;C12N1/20;

  • 国家 WO

  • 入库时间 2022-08-22 17:58:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号